Each study has a usefulness score out of 100 (rubric version 4.0). Tap a score to see what makes it up.
Highest usefulness score first. Studies without a score come last.
-
Alzheimer's disease (AD), an extremely common neurodegenerative disorder of the older generation, is one of the leading causes of death globally.
-
The acetylcholinesterase inhibitors donepezil and rivastigmine have been used as therapeutic drugs for Alzheimer's disease (AD), but their effects on LPS- and Aβ-induced neuroinflammatory responses and the underlying molecular pathways have not been studied in detail in vitro and in vivo.
-
Loss-of-function variants of triggering receptor expressed on myeloid cells 2 (TREM2) increase the risk of developing Alzheimer's disease (AD).
-
Alzheimer's disease (AD) is a progressive and fatal neurodegenerative disorder.
-
Vascular dementia (VaD) constitutes the second most prevalent cause of dementia in the world after Alzheimer's disease (AD).
-
Here, we report that the acute exposure of primary cortical neurons or synaptoneurosomes to APOE4 leads to a significant decrease in global protein synthesis.
-
As resident immune cells of the brain, microglia serve pivotal roles in regulating neuronal function under both physiological and pathological conditions, including aging and the most prevalent neurodegenerative disease, Alzheimer's disease (AD).
-
The ε4 allele of APOE-encoding apolipoprotein (ApoE) is one of the strongest genetic risk factors for Alzheimer's disease (AD).
-
Rare coding variants of the microglial triggering receptor expressed on myeloid cells 2 (TREM2) confer an increased risk for Alzheimer's disease (AD) characterized by the progressive accumulation of aggregated forms of amyloid β peptides (Aβ).
-
41/100
Alzheimer's disease (AD) is the most common progressive neurodegenerative disease.
-
41/100
Alzheimer's disease (AD) is a neurodegenerative disorder with no clear causative event making the disease difficult to diagnose and treat.
-
One evident hallmark of Alzheimer's disease (AD) is the irregular accumulation of proteins due to changes in proteostasis involving endoplasmic reticulum (ER) stress.
-
Alzheimer's disease (AD) is a neurodegenerative disease characterized by an increasing deterioration of memory, which is concomitant with additional cognitive deficits.
-
Administration of DSS induced colitis, impaired spatial and recognition memory, activated microglia, and increased A1-like astrocyte numbers.
-
The autophagy-lysosomal pathway plays a critical role in intracellular clearance and metabolic homeostasis.
-
Amyloid beta (Aβ)-induced abnormal neuroinflammation is recognized as a major pathological feature of Alzheimer's disease (AD), which results in memory impairment.
-
Clinical trials of new drugs for Alzheimer's disease (AD) have ended with disappointing results, with tremendous resources and time.
-
Immune surveillance is an essential process that safeguards the homeostasis of a healthy brain.
-
Metformin is one of the most widely prescribed hypoglycemic drugs and has the potential to treat many diseases.
-
41/100
Presbycusis contributes to cognitive decline and Alzheimer's disease.
-
Increased cerebrovascular amyloid-β (Aβ) deposition represents the main pathogenic mechanisms characterizing Alzheimer's disease (AD) and cerebral amyloid angiopathy (CAA).
-
41/100
Vascular dementia is the second leading cause of dementia after Alzheimer's disease in the elderly population worldwide.
-
Here, we demonstrated for the first time that CD3-CD122+NK1.1+ precursor NK (pNK) cells expressed TREM2 and their population increased in TREM2-overexpressing transgenic (TREM2-TG) mice compared with that in female C57BL/6 J wild type (WT) mice.
-
The vascular endothelial growth factor (VEGF) pathway regulates key processes in synapse function, which are disrupted in early stages of Alzheimer's disease (AD) by toxic-soluble amyloid-beta oligomers (Aβo).
-
41/100
Neurodegeneration is a debilitating condition that causes nerve cell degeneration or death.
From across this topic
10 of the 730 studies in this topic, picked by a fixed rule (a hash of each study's address), not by score or date; each page of this list shows a different 10. The same 10 appear here every time.
- Interferon γ: a master cytokine in microglia-mediated neural network dysfunction and neurodegeneration
- The blood-brain barrier in brain homeostasis and neurological diseases
- Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice
- Functional insight into LOAD-associated microglial response genes
- A rapid, genetically-tractable human iPSC-derived model for studying tissue-resident macrophage biology in Alzheimer’s and other diseases
- Amyloid Beta-Mediated Neurovascular Toxicity in Alzheimer's Disease
- Microglia and its Genetics in Alzheimer's Disease
- NLRP3 Inflammasome: A Starring Role in Amyloid-β- and Tau-Driven Pathological Events in Alzheimer's Disease
- Inflammatory mediators in the elderly
- Hypertension enhances Aβ-induced neurovascular dysfunction, promotes β-secretase activity, and leads to amyloidogenic processing of APP